Covid-19 vaccine update: EU regulator authorises AstraZeneca vaccine for all adults

By: |
January 29, 2021 9:53 PM

The European Medicines Agency licensed the vaccine to be used in people 18 and over, though concerns had been raised this week that not enough data exist to prove it works in older people.

Covid vaccineThe European Commission is expected to ask EU member-countries to support plans for added controls on vaccine exports.

Regulators authorised AstraZeneca’s coronavirus vaccine for use in adults throughout the European Union on Friday, amid criticism the bloc is not moving fast enough to vaccinate its population.

The European Medicines Agency licensed the vaccine to be used in people 18 and over, though concerns had been raised this week that not enough data exist to prove it works in older people.

The shot is the third COVID-19 vaccine given the greenlight by the European Medicines Agency, after ones made by Pfizer and Moderna. Both were authorized for all adults.

Many countries on the continent have been struggling to vaccinate people as quickly as Britain, Israel, the U.S. and elsewhere, and it was long hoped that the AstraZeneca shot would help speed things up. On top of the recent news that the drugmaker would supply fewer doses in an initial batch, there were concerns that an age restriction would further hamper Europe’s vaccination program.

Some doctors feared restricting the vaccine’s use in older people might worsen the pandemic’s impact, since older people have suffered more severe disease and died at a higher rate from the coronavirus.

But in its decision Friday, the European agency said the AstraZeneca vaccine, developed with Oxford University, would be recommended for use all adults.

While the AstraZeneca vaccine has been authorized for all adults in other countries, only 12 per cent of the participants in its research were over 55 and they were enrolled later, so there hasn’t been enough time to get results.

A large trial published last month showed the vaccine was about 70 per cent effective in preventing people from getting sick from the coronavirus, although it is unknown whether the shot stops disease transmission.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1States given 6.1 lakh Remdesivir vials, 15,801 oxygen cylinders, over 11,000 concentrators received as foreign aid: Centre
2Will examine data of 2-DG drug for adding it to national COVID treatment protocol: Govt
3Never exported vaccines at cost of people in India: Serum Institute